Annual Operating Profit
-$27.39 M
-$7.79 M-39.76%
30 June 2024
Summary:
Renovaro Biosciences annual operaing income is currently -$27.39 million, with the most recent change of -$7.79 million (-39.76%) on 30 June 2024. During the last 3 years, it has fallen by -$3.99 million (-17.04%). RENB annual operating profit is now -91499.67% below its all-time high of -$29.90 thousand, reached on 01 March 2012.RENB Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$5.72 M
-$259.50 K-4.75%
30 September 2024
Summary:
Renovaro Biosciences quarterly operating income is currently -$5.72 million, with the most recent change of -$259.50 thousand (-4.75%) on 30 September 2024. Over the past year, it has increased by +$3.16 million (+35.57%).RENB Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$24.23 M
+$3.16 M+11.54%
30 September 2024
Summary:
Renovaro Biosciences TTM operating income is currently -$24.23 million, with the most recent change of +$3.16 million (+11.54%) on 30 September 2024. Over the past year, it has dropped by -$2.94 million (-13.80%).RENB TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.8% | +35.6% | -13.8% |
| 3 y3 years | -17.0% | +9.6% | +22.0% |
| 5 y5 years | -149.2% | -103.1% | -140.9% |
RENB Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -39.8% | at low | -44.0% | +35.6% | -23.6% | +24.4% |
| 5 y | 5 years | -149.2% | at low | -103.1% | +59.6% | -140.9% | +24.4% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +59.6% | <-9999.0% | +24.4% |
Renovaro Biosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.72 M(+4.7%) | -$24.23 M(-11.5%) |
| June 2024 | -$27.39 M(+39.8%) | -$5.46 M(-37.7%) | -$27.39 M(+5.8%) |
| Mar 2024 | - | -$8.77 M(+105.4%) | -$25.90 M(+22.2%) |
| Dec 2023 | - | -$4.27 M(-51.9%) | -$21.19 M(-0.5%) |
| Sept 2023 | - | -$8.88 M(+123.5%) | -$21.29 M(+8.6%) |
| June 2023 | -$19.60 M(-14.1%) | - | - |
| June 2023 | - | -$3.98 M(-2.2%) | -$19.60 M(-4.8%) |
| Mar 2023 | - | -$4.06 M(-7.0%) | -$20.58 M(+0.1%) |
| Dec 2022 | - | -$4.37 M(-39.3%) | -$20.55 M(-8.7%) |
| Sept 2022 | - | -$7.19 M(+45.1%) | -$22.51 M(-1.4%) |
| June 2022 | -$22.83 M(-2.5%) | -$4.96 M(+22.8%) | -$22.83 M(-28.8%) |
| Mar 2022 | - | -$4.03 M(-36.3%) | -$32.05 M(+3.2%) |
| Dec 2021 | - | -$6.33 M(-15.6%) | -$31.07 M(+10.8%) |
| Sept 2021 | - | -$7.50 M(-47.1%) | -$28.05 M(+19.9%) |
| June 2021 | -$23.40 M(+96.3%) | -$14.18 M(+364.5%) | -$23.40 M(+94.2%) |
| Mar 2021 | - | -$3.05 M(-7.6%) | -$12.05 M(-6.0%) |
| Dec 2020 | - | -$3.31 M(+15.6%) | -$12.83 M(+3.9%) |
| Sept 2020 | - | -$2.86 M(+0.9%) | -$12.34 M(+3.5%) |
| June 2020 | -$11.92 M(+8.5%) | -$2.83 M(-26.0%) | -$11.92 M(+6.5%) |
| Mar 2020 | - | -$3.83 M(+35.9%) | -$11.20 M(+11.4%) |
| Dec 2019 | - | -$2.82 M(+15.4%) | -$10.06 M(-13.4%) |
| Sept 2019 | - | -$2.44 M(+15.8%) | -$11.62 M(+5.7%) |
| June 2019 | -$10.99 M(+106.2%) | -$2.11 M(-21.4%) | -$10.99 M(+21.3%) |
| Mar 2019 | - | -$2.69 M(-38.7%) | -$9.06 M(-5.7%) |
| Dec 2018 | - | -$4.38 M(+141.7%) | -$9.62 M(+47.6%) |
| Sept 2018 | - | -$1.81 M(+888.5%) | -$6.52 M(+22.3%) |
| June 2018 | -$5.33 M | -$183.40 K(-94.3%) | -$5.33 M(-8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$3.24 M(+152.8%) | -$5.79 M(+99.4%) |
| Dec 2017 | - | -$1.28 M(+104.7%) | -$2.91 M(+33.7%) |
| Sept 2017 | - | -$625.80 K(-3.5%) | -$2.17 M(-9.4%) |
| June 2017 | -$2.40 M(+13.2%) | -$648.30 K(+84.7%) | -$2.40 M(-0.9%) |
| Mar 2017 | - | -$351.00 K(-36.0%) | -$2.42 M(-6.3%) |
| Dec 2016 | - | -$548.80 K(-35.6%) | -$2.59 M(-1.8%) |
| Sept 2016 | - | -$852.30 K(+27.0%) | -$2.63 M(+24.1%) |
| June 2016 | -$2.12 M(-22.4%) | -$671.00 K(+30.6%) | -$2.12 M(+46.3%) |
| Mar 2016 | - | -$513.60 K(-13.7%) | -$1.45 M(-19.5%) |
| Dec 2015 | - | -$594.90 K(+74.3%) | -$1.80 M(-15.9%) |
| Sept 2015 | - | -$341.40 K(-60.6%) | -$2.14 M(-25.7%) |
| June 2015 | -$2.73 M(+12.6%) | - | - |
| Mar 2015 | - | -$865.50 K(-7.5%) | -$2.88 M(+18.7%) |
| Dec 2014 | -$2.43 M(+6447.7%) | -$935.30 K(+82.1%) | -$2.43 M(+61.7%) |
| Sept 2014 | - | -$513.70 K(-9.6%) | -$1.50 M(+49.6%) |
| June 2014 | - | -$568.10 K(+37.9%) | -$1.00 M(+128.9%) |
| Mar 2014 | - | -$412.10 K(+4987.7%) | -$438.70 K(+1118.6%) |
| Dec 2013 | - | -$8100.00(-49.4%) | -$36.00 K(-4.0%) |
| Sept 2013 | - | -$16.00 K(+540.0%) | -$37.50 K(+31.6%) |
| June 2013 | - | -$2500.00(-73.4%) | -$28.50 K(-23.0%) |
| Mar 2013 | -$37.10 K(+24.1%) | -$9400.00(-2.1%) | -$37.00 K(+15.6%) |
| Dec 2012 | - | -$9600.00(+37.1%) | -$32.00 K(-5.3%) |
| Sept 2012 | - | -$7000.00(-36.4%) | -$33.80 K(-17.6%) |
| June 2012 | - | -$11.00 K(+150.0%) | -$41.00 K(+36.7%) |
| Mar 2012 | -$29.90 K(-12.8%) | -$4400.00(-61.4%) | -$30.00 K(+17.2%) |
| Dec 2011 | -$34.30 K | -$11.40 K(-19.7%) | -$25.60 K(+80.3%) |
| Sept 2011 | - | -$14.20 K(<-9900.0%) | -$14.20 K(<-9900.0%) |
| June 2011 | - | $0.00 | $0.00 |
FAQ
- What is Renovaro Biosciences annual operaing income?
- What is the all time high annual operating profit for Renovaro Biosciences?
- What is Renovaro Biosciences annual operating profit year-on-year change?
- What is Renovaro Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly operating profit year-on-year change?
- What is Renovaro Biosciences TTM operating income?
- What is the all time high TTM operating profit for Renovaro Biosciences?
- What is Renovaro Biosciences TTM operating profit year-on-year change?
What is Renovaro Biosciences annual operaing income?
The current annual operating profit of RENB is -$27.39 M
What is the all time high annual operating profit for Renovaro Biosciences?
Renovaro Biosciences all-time high annual operaing income is -$29.90 K
What is Renovaro Biosciences annual operating profit year-on-year change?
Over the past year, RENB annual operaing income has changed by -$7.79 M (-39.76%)
What is Renovaro Biosciences quarterly operating income?
The current quarterly operating profit of RENB is -$5.72 M
What is the all time high quarterly operating profit for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly operating income is $0.00
What is Renovaro Biosciences quarterly operating profit year-on-year change?
Over the past year, RENB quarterly operating income has changed by +$3.16 M (+35.57%)
What is Renovaro Biosciences TTM operating income?
The current TTM operating profit of RENB is -$24.23 M
What is the all time high TTM operating profit for Renovaro Biosciences?
Renovaro Biosciences all-time high TTM operating income is $0.00
What is Renovaro Biosciences TTM operating profit year-on-year change?
Over the past year, RENB TTM operating income has changed by -$2.94 M (-13.80%)